A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.
from Health https://ift.tt/30YYgMw
January 27, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
The Man in Room 117Andrey Shevelyov would rather live on the street than take antipsychotic medication. Should it be his decision to make? from NYT > Health https://ift.tt/Q47oRbF … Read More
FDA Issues Warning of Cancer Risk Tied to CAR-T TherapiesThe agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning. from NYT > Health https://ift.tt/dbp… Read More
Philips Suspends Sales of CPAP and Other Breathing Devices After RecallUnder a settlement with regulators, the company must revamp some operations before resuming sales of its CPAP and ventilator devices in the United States. from NYT > Health https://ift.tt/r1KVZmL … Read More
Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity DrugsStarting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound. from NYT > Health https://ift.tt/qk8HD7C … Read More
Phones Track Everything but Their Role in Car WrecksDistracted driving is a worsening problem, safety experts say. Yet there is still no definitive database of the number of crashes or fatalities caused by it. from NYT > Health https://ift.tt/OSQyPA5 … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment